Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
Moderna(MRNA) stock is priced at $136.00, giving the company a market capitalization of 55.07B. It carries a P/E multiple of -17.28.
During the trading session on 2026-08-31, Moderna(MRNA) shares reached a daily high of $145.11 and a low of $133.33. At a current price of $136.00, the stock is +2.0% higher than the low and still -6.3% under the high.
Trading volume for Moderna(MRNA) stock has reached 25.82M, versus its average volume of 54.8M.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $176.66 and a low of $22.28.
MRNA News
Moderna (NasdaqGS:MRNA) received FDA approval for its updated 2026-2027 COVID-19 vaccines Spikevax and mNEXSPIKE targeting new SARS-CoV-2 variants. The decisio...
...
(RTTNews) - Shares of Moderna, Inc. (MRNA) are falling around 6 percent on Friday morning after the company announced pricing of a $2.6 billion private offering...
Analyst ratings
65%
of 26 ratingsMore MRNA News
Investing BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat A single trial readout is reshuffling the mRNA vacci...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as...
Shares of Moderna Inc. (NASDAQ:MRNA) are trading lower Friday morning after the company announced official terms for a major private debt offering. Here’s what...
As previously reported, Argus upgraded Moderna (MRNA) to Buy from Hold with an $180 price target following the company’s announcement of FDA approval for update...
Moderna (MRNA) announced the pricing of $2.6B aggregate principal amount of 0.00% Convertible Senior Notes due 2032 in a private placement only to persons reaso...
Moderna (MRNA) announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for...
Moderna, Inc. (NASDAQ:MRNA) stock is trading lower on Thursday after the company proposed a private placement of $2 billion of convertible senior notes due in 2...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.